IL2 and sarcoidosis: Thus, assuming that the modeling conditions accurately depict the mechanisms regulating granuloma formation in the setting of sarcoidosis, careful titration of combination therapy with anti-IL-2 and anti-IFNγ is predicted to effectively attenuate disease activity.